Literature DB >> 9864414

Stage II vaginal cancer responding to chemotherapy with irinotecan and cisplatin: a case report.

N Umesaki1, N Kawamura, A Tsujimura, T Ichimura, T Tanaka, S Ogita.   

Abstract

We report a patient with stage II primary vaginal cancer whose tumor disappeared on magnetic resonance imaging after a single course of neoajuvant chemotherapy using irinotecan and cisplatin. The regimen was 60 mg/m2 of cisplatin (day 1) and 60 mg/m2 of irinotecan (days 1, 8, 15). After addition of 1 course of cisplatin alone, radical surgery was performed. Histological examination of the excised tissue revealed no cancer cells. This is the first report on the good efficacy of chemotherapy with irinotecan and cisplatin for advanced vaginal cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864414     DOI: 10.3892/or.6.1.123

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

Review 1.  Innovations in the Management of Vaginal Cancer.

Authors:  Anjali Kulkarni; Nupur Dogra; Tiffany Zigras
Journal:  Curr Oncol       Date:  2022-04-27       Impact factor: 3.109

2.  Effects of neoadjuvant chemotherapy on patients with primary vaginal squamous cell carcinoma.

Authors:  Yuchao Diao; Jinwen Jiao; Kejuan Song; Lei Wang; Teng Lv; Shuzhen Dai; Qin Yao
Journal:  Mol Clin Oncol       Date:  2017-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.